Pimecrolimus - advancing towards long-term management of inflammatory skin diseases

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1281, 2001-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pimecrolimus for the treatment of inflammatory skin disease

By Wolff Klaus Stuetz Anton

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 643-655

Informa Healthcare

Access to resources Recommend Favorite

Pimecrolimus: an effective long-term therapy for atopic dermatitis

Inpharma, Vol. 1, Iss. 1329, 2002-01 ,pp. : 15-17

Adis International

Access to resources Recommend Favorite

Keratinocytes in Inflammatory Skin Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 329-334

Bentham Science Publishers

Access to resources Recommend Favorite

Safety concerns with the long-term management of osteoporosis

By Reginster Jean-Yves

Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. : 507-522

Informa Healthcare

Access to resources Recommend Favorite

Evaluating long-term management strategies for erosive oesophagitis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite